Payment overview · 2025
General Payments
$1,664.64
43 reported records · 21 companies
Healthcare provider profile · identity verified
Claudio Manubens, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease · DAVENPORT, FL · NPI 1992700363
Verified facts
What the public records show
CMS Open Payments records show Claudio Manubens, M.D. received $1,664.64 in general payments during 2025 across 43 reported records.
Medtronic, Inc. accounted for 17.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 27 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Jardiance.
Bayer Healthcare Pharmaceuticals Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Adempas as an associated drug or biological on 3385 records involving 1868 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Adempas by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 232 claims for Jardiance by this doctor in 2024.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 1301 claims for Eliquis by this doctor in 2024.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 171 claims for Entresto by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1301 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$283.64 | 17.0% | 4 | 2025 |
| BIOTRONIK INC. | Unresolved — no canonical attribution shown | $231.70 | 13.9% | 2 | 2025 |
| Actelion Pharmaceuticals US, Inc. | Unresolved — no canonical attribution shown | $147.96 | 8.9% | 3 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $145.79 | 8.8% | 4 | 2025 |
| Impulse Dynamics (USA) Inc. | Unresolved — no canonical attribution shown | $128.54 | 7.7% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $103.73 | 6.2% | 3 | 2025 |
| Insulet Corporation | Unresolved — no canonical attribution shown | $101.74 | 6.1% | 1 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $91.27 | 5.5% | 4 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $62.08 | 3.7% | 3 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $60.31 | 3.6% | 3 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $48.31 | 2.9% | 3 | 2025 |
| HEARTFLOW, INC. | Unresolved — no canonical attribution shown | $41.11 | 2.5% | 1 | 2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $32.10 | 1.9% | 2 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $31.22 | 1.9% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $30.63 | 1.8% | 2 | 2025 |
| Kestra Medical Technology Services, Inc. | Unresolved — no canonical attribution shown | $27.29 | 1.6% | 1 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $24.40 | 1.5% | 1 | 2025 |
| SCPHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $22.25 | 1.3% | 1 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $20.63 | 1.2% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $19.56 | 1.2% | 1 | 2025 |
| CVRx, Inc. | Unresolved — no canonical attribution shown | $10.38 | 0.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $1,565.65 | 42 |
| Education | $98.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BIOMONITOR Normalized: biomonitor |
Device | BIOTRONIK INC. | $231.70 | 2 | 2025 |
Source payment records
|
|||||
| TURBOHAWK Normalized: turbohawk |
Device | Medtronic, Inc. | $151.06 | 3 | 2025 |
Source payment records
|
|||||
| OPSUMIT Normalized: opsumit |
Drug | Actelion Pharmaceuticals US, Inc. | $147.96 | 3 | 2025 |
Source payment records
|
|||||
| CAMZYOS Normalized: camzyos |
Drug | E.R. Squibb & Sons, L.L.C. | $145.79 | 4 | 2025 |
Source payment records
|
|||||
| MICRA Normalized: micra |
Device | Medtronic, Inc. | $132.58 | 1 | 2025 |
Source payment records
|
|||||
| Optimizer Normalized: optimizer |
Device | Impulse Dynamics (USA) Inc. | $128.54 | 1 | 2025 |
Source payment records
|
|||||
| OMNIPOD Normalized: omnipod |
Device | Insulet Corporation | $101.74 | 1 | 2025 |
Source payment records
|
|||||
| UPTRAVI Normalized: uptravi |
Drug | Actelion Pharmaceuticals US, Inc. | $98.99 | 1 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $91.27 | 4 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $62.08 | 3 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $48.31 | 3 | 2025 |
Source payment records
|
|||||
| ENSITE PRECISION Normalized: ensite precision |
Device | Abbott Laboratories | $45.69 | 1 | 2025 |
Source payment records
|
|||||
| FFRct Normalized: ffrct |
Device | HEARTFLOW, INC. | $41.11 | 1 | 2025 |
Source payment records
|
|||||
| JOT DX Normalized: jot dx |
Device | Abbott Laboratories | $33.81 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $32.10 | 2 | 2025 |
Source payment records
|
|||||
| SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia |
Device | Edwards Lifesciences Corporation | $31.22 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $30.63 | 2 | 2025 |
Source payment records
|
|||||
| Assure WCD Normalized: assure wcd |
Device | Kestra Medical Technology Services, Inc. | $27.29 | 1 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL Normalized: mynx control |
Device | CORDIS US CORP. | $24.40 | 1 | 2025 |
Source payment records
|
|||||
| AMPLATZER AMULET Normalized: amplatzer amulet |
Device | Abbott Laboratories | $24.23 | 1 | 2025 |
Source payment records
|
|||||
| FUROSCIX Normalized: furoscix |
Drug | SCPHARMACEUTICALS INC. | $22.25 | 1 | 2025 |
Source payment records
|
|||||
| ATRICLIP LAA EXCLUSION SYSTEM Normalized: atriclip laa exclusion system |
Device | AtriCure, Inc. | $20.63 | 1 | 2025 |
Source payment records
|
|||||
| EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Normalized: epi sense guided coagulation system with visitrax |
Device | AtriCure, Inc. | $20.63 | 1 | 2025 |
Source payment records
|
|||||
| VYNDAQEL Normalized: vyndaqel |
Drug | PFIZER INC. | $20.29 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $19.56 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $18.60 | 1 | 2025 |
Source payment records
|
|||||
| Barostim Neo System Normalized: barostim neo system |
Device | CVRx, Inc. | $10.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 1301 | exact normalized | Medicare Part D |
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 232 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. Exact reporting entity; no affiliate inference |
2025 | Adempas open payments reported associated product |
CMS Open Payments — General Payments 3385 supporting records · 1868 recipient NPIs · example record 1225434673 |
Adempas · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
232 | 45 |
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1301 | 220 |
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
171 | 37 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1301 | 220 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
15 | 15 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2274 | 424 |
| Furosemide | Furosemide | 1609 | 336 |
| Amlodipine Besylate | Amlodipine Besylate | 1561 | 319 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1332 | 225 |
| Eliquis | Apixaban | 1301 | 220 |
| Losartan Potassium | Losartan Potassium | 1187 | 252 |
| Potassium Chloride | Potassium Chloride | 1074 | 186 |
| Pantoprazole Sodium | Pantoprazole Sodium | 980 | 180 |
| Metoprolol Tartrate | Metoprolol Tartrate | 971 | 220 |
| Lisinopril | Lisinopril | 905 | 178 |
| Gabapentin | Gabapentin | 904 | 165 |
| Clopidogrel | Clopidogrel Bisulfate | 840 | 183 |
| Metoprolol Succinate | Metoprolol Succinate | 774 | 179 |
| Donepezil Hcl | Donepezil Hcl | 627 | 107 |
| Omeprazole | Omeprazole | 627 | 101 |
| Tramadol Hcl | Tramadol Hcl | 618 | 167 |
| Carvedilol | Carvedilol | 596 | 142 |
| Sertraline Hcl | Sertraline Hcl | 588 | 102 |
| Metformin Hcl | Metformin Hcl | 586 | 104 |
| Trazodone Hcl | Trazodone Hcl | 569 | 132 |
| Tamsulosin Hcl | Tamsulosin Hcl | 559 | 101 |
| Escitalopram Oxalate | Escitalopram Oxalate | 558 | 109 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 527 | 97 |
| Memantine Hcl | Memantine Hcl | 490 | 84 |
| Mirtazapine | Mirtazapine | 399 | 85 |
| Famotidine | Famotidine | 375 | 77 |
| Levetiracetam | Levetiracetam | 366 | 50 |
| Pravastatin Sodium | Pravastatin Sodium | 361 | 77 |
| Ezetimibe | Ezetimibe | 345 | 90 |
| Hydralazine Hcl | Hydralazine Hcl | 329 | 72 |
| Quetiapine Fumarate | Quetiapine Fumarate | 322 | 81 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 319 | 82 |
| Xarelto | Rivaroxaban | 312 | 59 |
| Spironolactone | Spironolactone | 296 | 69 |
| Midodrine Hcl | Midodrine Hcl | 289 | 60 |
| Lactulose | Lactulose | 284 | 87 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 279 | 45 |
| Divalproex Sodium | Divalproex Sodium | 275 | 68 |
| Simvastatin | Simvastatin | 272 | 54 |
| Lorazepam | Lorazepam | 264 | 92 |
| Methenamine Hippurate | Methenamine Hippurate | 263 | 42 |
| Alprazolam | Alprazolam | 252 | 60 |
| Duloxetine Hcl | Duloxetine Hcl | 247 | 60 |
| Sucralfate | Sucralfate | 237 | 39 |
| Jardiance | Empagliflozin | 232 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 231 | 44 |
| Buspirone Hcl | Buspirone Hcl | 219 | 53 |
| Glipizide | Glipizide | 217 | 34 |
| Clonidine Hcl | Clonidine Hcl | 209 | 65 |
| Oxybutynin Chloride | Oxybutynin Chloride | 203 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 202 | 74 |
| Allopurinol | Allopurinol | 199 | 39 |
| Olanzapine | Olanzapine | 198 | 42 |
| Prednisone | Prednisone | 197 | 78 |
| Latanoprost | Latanoprost | 195 | 42 |
| Montelukast Sodium | Montelukast Sodium | 185 | 32 |
| Megestrol Acetate | Megestrol Acetate | 182 | 51 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 181 | 22 |
| Celecoxib | Celecoxib | 180 | 35 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 178 | 132 |
| Ondansetron Hcl | Ondansetron Hcl | 178 | 75 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 173 | 120 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 172 | 37 |
| Entresto | Sacubitril/Valsartan | 171 | 37 |
| Ropinirole Hcl | Ropinirole Hcl | 167 | 29 |
| Pregabalin | Pregabalin | 164 | 29 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 162 | 29 |
| Repatha Sureclick | Evolocumab | 159 | 29 |
| Finasteride | Finasteride | 157 | 28 |
| Clonazepam | Clonazepam | 155 | 28 |
| Glimepiride | Glimepiride | 154 | 22 |
| Baclofen | Baclofen | 152 | 32 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 150 | 69 |
| Fenofibrate | Fenofibrate Nanocrystallized | 150 | 21 |
| Amiodarone Hcl | Amiodarone Hcl | 144 | 32 |
| Risperidone | Risperidone | 140 | 24 |
| Cephalexin | Cephalexin | 135 | 95 |
| Januvia | Sitagliptin Phosphate | 133 | 19 |
| Nystatin | Nystatin | 131 | 70 |
| Temazepam | Temazepam | 129 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 122 | 33 |
| Alendronate Sodium | Alendronate Sodium | 121 | 22 |
| Atenolol | Atenolol | 117 | 25 |
| Bumetanide | Bumetanide | 116 | 24 |
| Azithromycin | Azithromycin | 114 | 97 |
| Levofloxacin | Levofloxacin | 113 | 87 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 111 | 25 |
| Diclofenac Sodium | Diclofenac Sodium | 111 | 36 |
| Warfarin Sodium | Warfarin Sodium | 106 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 105 | 21 |
| Ranolazine Er | Ranolazine | 105 | 31 |
| Topiramate | Topiramate | 105 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 104 | 28 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 101 | 27 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 100 | 20 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 99 | 28 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 99 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 96 | 15 |
| Nifedipine Er | Nifedipine | 95 | 19 |
| Trulicity | Dulaglutide | 92 | 19 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 91 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 90 | 33 |
| Diltiazem 24hr Er | Diltiazem Hcl | 87 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 87 | 28 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 87 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 86 | 66 |
| Nitroglycerin | Nitroglycerin | 81 | 42 |
| Myrbetriq | Mirabegron | 80 | 12 |
| Primidone | Primidone | 80 | 13 |
| Albuterol Sulfate | Albuterol Sulfate | 79 | 18 |
| Digoxin | Digoxin | 79 | 18 |
| Aripiprazole | Aripiprazole | 78 | 22 |
| Diltiazem Hcl | Diltiazem Hcl | 77 | 13 |
| Cholestyramine | Cholestyramine (With Sugar) | 75 | 23 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 74 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 73 | 25 |
| Meclizine Hcl | Meclizine Hcl | 72 | 24 |
| Meloxicam | Meloxicam | 70 | 18 |
| Ketoconazole | Ketoconazole | 69 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 67 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 65 | 27 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 64 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 63 | 11 |
| Divalproex Sodium Er | Divalproex Sodium | 60 | 13 |
| Levemir Flexpen | Insulin Detemir | 60 | 15 |
| Lamotrigine | Lamotrigine | 59 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 59 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 58 | 22 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 58 | suppressed |
| Bupropion Xl | Bupropion Hcl | 57 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 57 | 31 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 57 | 44 |
| Timolol Maleate | Timolol Maleate | 57 | 14 |
| Glipizide Er | Glipizide | 56 | suppressed |
| Mupirocin | Mupirocin | 55 | 27 |
| Brimonidine Tartrate | Brimonidine Tartrate | 54 | 15 |
| Fluconazole | Fluconazole | 54 | 42 |
| Hydrocortisone | Hydrocortisone | 54 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 54 | 16 |
| Ammonium Lactate | Ammonium Lactate | 53 | 27 |
| Incruse Ellipta | Umeclidinium Bromide | 53 | 12 |
| Methocarbamol | Methocarbamol | 53 | 14 |
| Anastrozole | Anastrozole | 52 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 52 | 11 |
| Valsartan | Valsartan | 52 | 17 |
| Methimazole | Methimazole | 51 | suppressed |
| Tradjenta | Linagliptin | 50 | suppressed |
| Loperamide | Loperamide Hcl | 49 | 25 |
| Constulose | Lactulose | 48 | 13 |
| Ibuprofen | Ibuprofen | 47 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | suppressed |
| Nystop | Nystatin | 46 | 28 |
| Torsemide | Torsemide | 46 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 44 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 43 | 17 |
| Amoxicillin | Amoxicillin | 42 | 23 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 42 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 42 | 16 |
| Ozempic | Semaglutide | 42 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 42 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 41 | suppressed |
| Calcitriol | Calcitriol | 41 | suppressed |
| Carbamazepine | Carbamazepine | 41 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 41 | 18 |
| Oxcarbazepine | Oxcarbazepine | 41 | suppressed |
| Folic Acid | Folic Acid | 40 | suppressed |
| Ondansetron Odt | Ondansetron | 40 | 16 |
| Rivastigmine | Rivastigmine Tartrate | 40 | suppressed |
| Sotalol | Sotalol Hcl | 40 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 37 | 19 |
| Ipratropium Bromide | Ipratropium Bromide | 37 | suppressed |
| Metolazone | Metolazone | 37 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 36 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 36 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 36 | suppressed |
| Vascepa | Icosapent Ethyl | 36 | suppressed |
| Budesonide | Budesonide | 35 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 35 | suppressed |
| Olanzapine Odt | Olanzapine | 35 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 34 | suppressed |
| Synthroid | Levothyroxine Sodium | 34 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 34 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 33 | 11 |
| Morphine Sulfate | Morphine Sulfate | 33 | 26 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 32 | suppressed |
| Methylprednisolone | Methylprednisolone | 32 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 32 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 32 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 31 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 31 | 15 |
| Estradiol | Estradiol | 29 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 29 | suppressed |
| Tivicay | Dolutegravir Sodium | 29 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 28 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 27 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 27 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 27 | 15 |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 27 | 16 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 26 | suppressed |
| Dutasteride | Dutasteride | 26 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Indapamide | Indapamide | 26 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Lovastatin | Lovastatin | 26 | suppressed |
| Irbesartan | Irbesartan | 25 | suppressed |
| Lansoprazole | Lansoprazole | 25 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 25 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 24 | suppressed |
| Fentanyl | Fentanyl | 24 | suppressed |
| Levemir | Insulin Detemir | 24 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 24 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 23 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Lacosamide | Lacosamide | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 22 | suppressed |
| Enulose | Lactulose | 22 | suppressed |
| Mounjaro | Tirzepatide | 22 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 22 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 22 | suppressed |
| Amantadine | Amantadine Hcl | 21 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 21 | suppressed |
| Clonidine | Clonidine | 21 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 21 | suppressed |
| Phenobarbital | Phenobarbital | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 16 |
| Erythromycin | Erythromycin Base | 20 | 17 |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 20 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 20 | suppressed |
| Adempas | Riociguat | 19 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Niacin Er | Niacin | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 18 | suppressed |
| Cefdinir | Cefdinir | 18 | 13 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 18 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 18 | 14 |
| Methotrexate | Methotrexate Sodium | 18 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | suppressed |
| Acetazolamide | Acetazolamide | 17 | suppressed |
| Besivance | Besifloxacin Hcl | 17 | suppressed |
| Fycompa | Perampanel | 17 | suppressed |
| Movantik | Naloxegol Oxalate | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Darunavir | Darunavir | 16 | suppressed |
| Glyburide | Glyburide | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Linzess | Linaclotide | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Ritonavir | Ritonavir | 16 | suppressed |
| Novolog | Insulin Aspart | 15 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 15 | 15 |
| Phenytoin | Phenytoin | 15 | suppressed |
| Qvar Redihaler | Beclomethasone Dipropionate | 15 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 15 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 15 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Cyclosporine | Cyclosporine | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Gemtesa | Vibegron | 14 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 14 | suppressed |
| Roflumilast | Roflumilast | 14 | suppressed |
| Ambrisentan | Ambrisentan | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Insulin Aspart | Insulin Aspart | 13 | suppressed |
| Jantoven | Warfarin Sodium | 13 | suppressed |
| Klor-Con | Potassium Chloride | 13 | suppressed |
| Mesalamine Dr | Mesalamine | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Glucagon Emergency Kit | Glucagon | 12 | suppressed |
| Humalog Mix 50-50 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Risperidone Odt | Risperidone | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Azathioprine | Azathioprine | 11 | suppressed |
| Bicalutamide | Bicalutamide | 11 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Insulin Degludec | Insulin Degludec | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,664.64 · 43 records | Medtronic, Inc. | AMPLATZER AMULET, ATRICLIP LAA EXCLUSION SYSTEM, Assure WCD, BIOMONITOR, Barostim Neo System, CAMZYOS, ELIQUIS, ENSITE PRECISION, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, FFRct, FUROSCIX, JARDIANCE, JOT DX, Kerendia, LEQVIO, LifeVest, MICRA, MYNX CONTROL, OMNIPOD, OPSUMIT, Optimizer, REPATHA, REXULTI, SAPIEN 3 Ultra RESILIA, TURBOHAWK, UPTRAVI, VYNDAQEL | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Bayer Healthcare Pharmaceuticals Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error